Omita y vaya al Contenido

Alga noruega o nudosa


¿Qué es?

El alga noruega (bladderwrack) es un tipo de alga marina. La gente usa la planta entera para hacer los medicamentos.

El alga noruega se utiliza para el tratamiento de muchas afecciones, pero, hasta el momento no hay suficiente evidencia científica para determinar si es eficaz para cualquiera de ellas. Es también importante señalar que no es seguro tomar el alga noruega por vía oral.

El alga noruega es utilizada para los trastornos de la tiroides incluyendo una tiroides con baja actividad (mixedema), el agrandamiento de la glándula de la tiroides (bocio) y la deficiencia de yodo. También se utiliza para la obesidad, la artritis, el dolor de las articulaciones, “el endurecimiento de las arterias” (arteriosclerosis), los trastornos digestivos, la acidez, la “limpieza de la sangre,” el estreñimiento, la bronquitis, el enfisema, los trastornos del tracto urinario y la ansiedad. Otros usos incluyen estimulación del sistema inmunológico y aumento de la energía.

Algunas personas también aplican el alga noruega a la piel para el tratamiento de las enfermedades de la piel, las quemaduras, el envejecimiento de la piel y las mordeduras de insectos.

No confunda el alga noruega con la utricularia.

¿Qué tan efectivo es?

Natural Medicines Comprehensive Database (La Base Exhaustiva de Datos de Medicamentos Naturales) clasifica la eficacia, basada en evidencia científica, de acuerdo a la siguiente escala: Eficaz, Probablemente Eficaz, Posiblemente Eficaz, Posiblemente Ineficaz, Probablemente Ineficaz, Ineficaz, e Insuficiente Evidencia para Hacer una Determinación.

La clasificación de la eficacia para este producto es la siguiente:

Insuficiente evidencia para hacer una determinación para...

  • La obesidad. Investigaciones preliminares sugieren que el alga noruega, si se usa junto con lecitina y vitaminas, no ayuda a las personas a perder peso y a mantener la pérdida de peso.
  • Problemas de la tiroides, incluyendo la glándula de la tiroides agrandada (bocio).
  • La deficiencia de yodo.
  • La artritis.
  • Las articulaciones con dolor (reumatismo).
  • El “endurecimiento de las arterias” (arteriosclerosis).
  • Los problemas digestivos.
  • La “limpieza de la sangre”.
  • El estreñimiento.
  • Otras afecciones.
Se necesita más evidencia para aprobar al alga noruega para estos usos.

¿Cómo funciona?

Volver al comienzo
El alga noruega, como muchas plantas marinas, contiene cantidades variables de yodo, el que se usa para la prevención o el tratamiento de algunos trastornos de la tiroides. Los productos de alga noruega pueden contener cantidades variables de yodo, lo que hace que sea una fuente inconstante de yodo. El alga noruega también contiene algina, la que puede actuar como un laxante para ayudar el paso de las heces por los intestinos.

¿Hay preocupación por la seguridad de su uso?

Volver al comienzo
El alga noruega POSIBLEMENTE NO ES SEGURA. Podría contener altas concentraciones de yodo que podría causar o empeorar algunos problemas de la tiroides. El uso prolongado, y el uso de gran cantidad de yodo en la dieta están vinculados con el bocio y con un mayor riesgo de cáncer de la tiroides. El tratamiento de los problemas de la tiroides no debe hacerse sin supervisión médica.

Como otras plantas marinas, el alga noruega puede concentrar metales pesados tóxicos, tales como arsénico, del agua en la que vive.

Advertencias y precauciones especiales:

Embarazo y lactancia: El alga noruega es PROBABLEMENTE NO SEGURA durante el embarazo y la lactancia. No la use.

Problemas de la tiroides conocidos como hipertiroidismo (demasiada hormona de la tiroides), o hipotiroidismo (muy poca hormona de la tiroides): El alga noruega contiene cantidades significativas de yodo, lo que puede empeorar ya sea el hipertiroidismo o el hipotiroidismo. No las use.

La infertilidad: Investigaciones preliminares sugieren que el tomar alga noruega podría hacer más difícil que las mujeres queden embarazadas.

Alergia al yodo: El alga noruega contiene cantidades significativas de yodo, lo que podría causar reacciones alérgicas en las personas sensibles al yodo. No las use.

Cirugía: El alga noruega podría retardar la coagulación de la sangre. Hay preocupación de que podría causar más sangrado durante y después de la cirugía. Deje de tomar alga noruega por lo menos 2 semanas antes de someterse a una cirugía.

¿Existen interacciones con medicamentos?

Volver al comienzo

Moderadas

Tenga cuidado con esta combinación

Medicamentos para una tiroides hiperactiva (Fármacos antitiroides)
El alga noruega puede contener cantidades significativas de yodo. El yodo puede afectar a la tiroides. El tomar yodo junto con medicamentos para una tiroides hiperactiva podría disminuir demasiado los niveles de la tiroides. No tome alga noruega si está tomando medicamentos para una tiroides hiperactiva.

Algunos de setos medicamentos incluyen mandelato de metenamina (methimazole), metimazol (Tapazole), yoduro de potasio (Thyro-Block) y otros.

Medicamentos que retardan la coagulación sanguínea (Anticoagulantes / Fármacos antiplaquetarios)
El alga noruega podría retardar la coagulación sanguínea. El tomar alga noruega junto con medicamentos que también retardan la coagulación podría aumentar la posibilidad de producir hematomas y pérdida de sangre.

Algunos de los medicamentos que retardan la coagulación sanguínea incluyen aspirina, clopidogrel (Plavix), diclofenac (Voltaren, Cataflam, otros), ibuprofeno (Advil, Motrin, otros), naproxeno (Anaprox, Naprosyn, otros), dalteparin (Fragmin), enoxaparin (Lovenox), heparina, warfarina (Coumadin), y otros.

¿Existen interacciones con hierbas y suplementos?

Volver al comienzo
Hierbas y suplementos que podrían retardar la coagulación sanguínea
El alga noruega podría retardar la coagulación sanguínea. El tomar alga noruega junto con hierbas que también retardan la coagulación sanguínea podría aumentar las posibilidades de sufrir hematomas y pérdida de sangre. Estas hierbas incluyen angélica, el clavo de olor, la salvia miltiorrhiza, el fenugreco, la matricaria, el ajo, el jengibre, el ginkgo, el ginseng Panax, el álamo, el trébol rojo, la cúrcuma y otros.

¿Existen interacciones con alimentos?

Volver al comienzo
No se conoce ninguna interacción con alimentos.

¿Qué dosis se utiliza?

Volver al comienzo
La dosis apropiada de alga noruega depende de muchos factores tales como la edad de la persona, el estado de salud y varias otras condiciones. En este momento no hay suficiente información científica para determinar un rango de dosis apropiado para el uso del alga noruega. Tenga en mente que los productos naturales no son siempre necesariamente seguros y las dosis pueden ser importantes. Asegúrese de seguir las instrucciones en las etiquetas de los productos y consulte con su farmacéutico, doctor u otro proveedor de salud médica antes de usarlos.

Otros nombres

Volver al comienzo
Algue Laminaire, Ascophylle Noueuse, Ascophyllum nodosum, Atlantic Kelp, Black Tang, Bladder Fucus, Bladder Wrack, Blasentang, Chêne Marin, Cutweed, Fucus, Fucus Vésiculeux, Fucus vesiculosis, Goémon, Kelp, Kelpware, Kelp-Ware, Knotted Wrack, Laitue de Mer, Laitue Marine, Laminaire, Marine Oak, Meereiche, Norwegian Seaweed, Quercus Marina, Rockweed, Rockwrack, Schweintang, Sea Kelp, Seawrack, Tang, Varech, Varech Vésiculeux.

Metodología

Volver al comienzo
Para saber más sobre cómo este artículo fue escrito, refiérase a la metodología metodología (http://www.nlm.nih.gov/medlineplus/spanish/druginfo/natural/methodology-sp.html) de la Base exhaustiva de datos de medicamentos naturales.

Referencias

Volver al comienzo
Para ver todas las referencias de la página de Alga noruega o nudosa, por favor diríjase a http://www.nlm.nih.gov/medlineplus/spanish/druginfo/natural/726.html.
  1. Alraei, RG. Herbal and Dietary Supplements for Weight Loss. Topics in Clinical Nutrition. 2010;25:136-150.
  2. Bradley MD, Nelson A Petticrew M Cullum N Sheldon T. Dressing for pressure sores. Cochrane Library 2011;0:0.
  3. Schreuder SM, Vermeulen H Qureshi MA Ubbink DT. Dressings and topical agents for donor sites of split-thickness skin grafts. JOURNAL 2009;0:0.
  4. Martyn-St James M., O'Meara S. Foam dressings for venous leg ulcers. Cochrane Library. 2012;0:0.
  5. Ewart, S Girouard G. Tiller C. et al. Antidiabetic Activities of a Seaweed Extract. Diabetes. 2004;53(Supplement 2):A509.
  6. Lindsey, H. Use of Botanicals for Cancer: Systematic Research Required to Determine Role. Oncology Times. 2005;27:52-55.
  7. Le Tutour B, Benslimane F, Gouleau MP, and et al. Antioxidant and pro-oxidant activities of the brown algae, Laminaria digitata, Himanthalia elongata, Fucus vesiculosus, Fucus serratus and Ascophyllum nodosum. J Applied Phycology 1998;10:121-129.
  8. Schornack, J. Ocular Side Effects of Herbal Supplements. Contact Lens Spectrum. 2003;18:0.
  9. Iskandar, Fanny, Amiruddin, Muh Dali, Melati, Dewi, and Ilyas, Faridha S. The role of contact sensitization in contact dermatitis patients among the seaweed farmers in Bantaeng, South Sulawesi, Indonesia. World Allergy Organization Journal 2007;0:S56.
  10. Oguri T., Yoshinaga J. Tao H. Nakazato T. Cancer Risk Assessment of Inorganic Arsenic Among Japanese Population. Epidemiology. 2011;22:0.
  1. Taylor T., Czarnowski C. What caused this case of asymptomatic hyperthyroidism?: Everything pointed to an exogenous cause, but our patient denied taking anything. Only later did she mention a diet aid. Journal of Family Practice. 2009;58:203-206.
  2. Eliason, B. C. Transient hyperthyroidism in a patient taking dietary supplements containing kelp. J Am Board Fam.Pract. 1998;11:478-480. View abstract.
  3. Wang, C. and Yang, G. [Comparison of effects of two kinds of soluble algae polysaccharide on blood lipid, liver lipid, platelet aggregation and growth in rats]. Zhonghua Yu Fang Yi.Xue.Za Zhi. 1997;31:342-345. View abstract.
  4. Moss, T. M. Herbal medicine in the emergency department: a primer for toxicities and treatment. J.Emerg.Nurs. 1998;24:509-513. View abstract.
  5. Nishimura, Y., Ishii, N., Sugita, Y., and Nakajima, H. A case of carotenodermia caused by a diet of the dried seaweed called Nori. J.Dermatol. 1998;25:685-687. View abstract.
  6. Maguire, R. A., Zacharopoulos, V. R., and Phillips, D. M. Carrageenan-based nonoxynol-9 spermicides for prevention of sexually transmitted infections. Sex Transm.Dis. 1998;25:494-500. View abstract.
  7. Mauray, S., De, Raucourt E., Chaubet, F., Maiga-Revel, O., Sternberg, C., and Fischer, A. M. Comparative anticoagulant activity and influence on thrombin generation of dextran derivatives and of a fucoidan fraction. J.Biomater.Sci.Polym.Ed 1998;9:373-387. View abstract.
  8. Gaigi, S., Elati, J., Ben, Osman A., and Beji, C. [Experimental study of the effects of seaweed in the treatment of obesity]. Tunis Med. 1996;74:241-243. View abstract.
  9. Drozhzhina, V. A., Fedorov, IuA, Blokhin, V. P., Soboleva, T. I., and Kazakova, O. V. [The use of dental elixirs based on natural biologically active substances in the treatment and prevention of periodontal diseases]. Stomatologiia (Mosk) 1996;Spec No:52-53. View abstract.
  10. Burnett, J. W., Burnett, H. W., and Burnett, M. G. Sargassum dermatitis. Cutis 1997;59:303-304. View abstract.
  11. Yamamoto I, Nagumo T, Fujihara M, and et al. Antitumor effect of seaweeds. II. Fractionation and partial characterization of the polysaccharide with antitumor activity from Sargassum fulvellum. Jpn.J Exp Med 1977;47:133-140. View abstract.
  12. Monego, E. T., Peixoto, Mdo R., Jardim, P. C., Sousa, A. L., Braga, V. L., and Moura, M. F. [Different therapies in the treatment of obesity in hypertensive patients]. Arq Bras.Cardiol. 1996;66:343-347. View abstract.
  13. Vugia, D. J., Shefer, A. M., Douglas, J., Greene, K. D., Bryant, R. G., and Werner, S. B. Cholera from raw seaweed transported from the Philippines to California. J.Clin.Microbiol. 1997;35:284-285. View abstract.
  14. Riou D, Colliec-Jouault S, Pinczon du Sel D, and et al. Antitumor and antiproliferative effects of a fucan extracted from ascophyllum nodosum against a non-small-cell bronchopulmonary carcinoma line. Anticancer Res 1996;16(3A):1213-1218. View abstract.
  15. Sakata, T. A very-low-calorie conventional Japanese diet: its implications for prevention of obesity. Obes.Res. 1995;3 Suppl 2:233s-239s. View abstract.
  16. Ellouali M, Boisson-Vidal C, Durand P, and et al. Antitumor activity of low molecular weight fucans extracted from brown seaweed Ascophyllum nodosum. Anticancer Res 1993;13(6A):2011-2020. View abstract.
  17. Epstein, P. R. Algal blooms in the spread and persistence of cholera. Biosystems 1993;31(2-3):209-221. View abstract.
  18. Noguchi, T., Matsui, T., Miyazawa, K., Asakawa, M., Iijima, N., Shida, Y., Fuse, M., Hosaka, Y., Kirigaya, C., Watabe, K., and . Poisoning by the red alga 'ogonori' (Gracilaria verrucosa) on the Nojima Coast, Yokohama, Kanagawa Prefecture, Japan. Toxicon 1994;32:1533-1538. View abstract.
  19. Leemhuis, M. P. and Quarles van Ufford, A. C. [Iodine goiter and hypothyroidism when using seaweed preparations]. Ned.Tijdschr.Geneeskd. 7-5-1980;124:1119. View abstract.
  20. Drnek, F., Prokes, B., and Rydlo, O. [Experiment in affecting cancer biologically with an intramuscular and local administration of the seaweed, Scenedesmus obliquus]. Cesk.Gynekol. 1981;46:463-465. View abstract.
  21. Yamaguchi, K., Fukushima, H., Uzawa, H., Iseki, T., Shiroozu, A., and Inoue, K. [A case of iodide myxedema observed for 3 years under a low iodide diet--especially on the restoration of the mechanism of escape from the Wolff-Chaikoff effect]. Nihon Naibunpi Gakkai Zasshi 1-20-1984;60:79-88. View abstract.
  22. Fisher, A. A. Water-related dermatoses. Part I. Cutis 1980;25:132, 135-132, 140. View abstract.
  23. Teas, J. The dietary intake of Laminaria, a brown seaweed, and breast cancer prevention. Nutr Cancer 1983;4:217-222. View abstract.
  24. Criado, M. T. and Ferreiros, C. M. Selective interaction of a Fucus vesiculosus lectin-like mucopolysaccharide with several Candida species. Ann Microbiol (Paris) 1983;134A:149-154. View abstract.
  25. Caporiccio, B., Braun, M., Vignaud, M., Chalet, M., Teste, J., Codomier, L., and Catayee, G. [Characteristics of the action of an acidic sulfated polysaccharide on global blood coagulation in vitro. Preliminary study in various species of mammals and in man]. C.R.Seances Soc.Biol.Fil. 1983;177:412-420. View abstract.
  26. Louekari, K. and Salminen, S. Intake of heavy metals from foods in Finland, West Germany and Japan. Food Addit.Contam 1986;3:355-362. View abstract.
  27. Shilo, S. and Hirsch, H. J. Iodine-induced hyperthyroidism in a patient with a normal thyroid gland. Postgrad Med J 1986;62:661-662. View abstract.
  28. van der Willigen, A. H., Habets, J. M., van, Joost T., Nienhuis, P. H., and Stolz, E. [Allergic contact eczema caused by Sargassum muticum in professional fishermen on Lake Grevelingen]. Ned.Tijdschr.Geneeskd. 12-24-1988;132:2355-2356. View abstract.
  29. van der Willigen, A. H., Habets, J. M., van, Joost T., Stolz, E., and Nienhuis, P. H. Contact allergy to iodine in Japanese sargassum. Contact Dermatitis 1988;18:250-252. View abstract.
  30. Jeanmougin, M., Lemarchand-Venencie, F., Hoang, X. D., D'Hondt, J. L., and Civatte, J. [Occupational eczema with photosensitivity caused by contact with Bryozoa]. Ann.Dermatol.Venereol. 1987;114:353-357. View abstract.
  31. Church FC, Meade JB, Treanor RE, and et al. Antithrombin activity of fucoidan. The interaction of fucoidan with heparin cofactor II, antithrombin III, and thrombin. J Biol Chem 2-25-1989;264:3618-3623. View abstract.
  32. Grauffel V, Kloareg B, Mabeau S, and et al. New natural polysaccharides with potent antithrombic activity: fucans from brown algae. Biomaterials 1989;10:363-368. View abstract.
  33. Ishizuki, Y., Yamauchi, K., and Miura, Y. [Transient thyrotoxicosis induced by Japanese kombu]. Nihon Naibunpi Gakkai Zasshi 2-20-1989;65:91-98. View abstract.
  34. Lamela M, Anca J, Villar R, and et al. Hypoglycemic activity of several seaweed extracts. J.Ethnopharmacol. 1989;27(1-2):35-43. View abstract.
  35. Maruyama H, Nakajima J, and Yamamoto I. A study on the anticoagulant and fibrinolytic activities of a crude fucoidan from the edible brown seaweed Laminaria religiosa, with special reference to its inhibitory effect on the growth of sarcoma-180 ascites cells subcutaneously implanted into mice. Kitasato Arch Exp Med 1987;60:105-121. View abstract.
  36. Hartman AA. [Hyperthyroidism during administration of kelp tablets]. Ned Tijdschr Geneeskd 7-14-1990;134:1373. View abstract.
  37. de Smet, P. A., Stricker, B. H., Wilderink, F., and Wiersinga, W. M. [Hyperthyroidism during treatment with kelp tablets]. Ned.Tijdschr.Geneeskd. 5-26-1990;134:1058-1059. View abstract.
  38. Leung, A. M. and Braverman, L. E. Iodine-induced thyroid dysfunction. Curr.Opin.Endocrinol.Diabetes Obes. 2012;19:414-419. View abstract.
  39. Fulton, J. A., Blasiole, K. N., Cottingham, T., Tornero, M., Graves, M., Smith, L. G., Mirza, S., and Mostow, E. N. Wound dressing absorption: a comparative study. Adv.Skin Wound.Care 2012;25:315-320. View abstract.
  40. Obiero, J., Mwethera, P. G., and Wiysonge, C. S. Topical microbicides for prevention of sexually transmitted infections. Cochrane.Database.Syst.Rev. 2012;6:CD007961. View abstract.
  41. Min, S. K., Han, S. M., Kim, H. T., Kwon, O. C., Lee, S., and Kim, J. K. Algal fucoidan, unlike heparin, has thrombolytic activity in a murine arterial thrombosis model. Blood Coagul.Fibrinolysis 2012;23:359-366. View abstract.
  42. Silberstein, E. B. Radioiodine: the classic theranostic agent. Semin.Nucl.Med. 2012;42:164-170. View abstract.
  43. Park, K. Y., Jang, W. S., Yang, G. W., Rho, Y. H., Kim, B. J., Mun, S. K., Kim, C. W., and Kim, M. N. A pilot study of silver-loaded cellulose fabric with incorporated seaweed for the treatment of atopic dermatitis. Clin.Exp.Dermatol. 2012;37:512-515. View abstract.
  44. Michikawa, T., Inoue, M., Shimazu, T., Sawada, N., Iwasaki, M., Sasazuki, S., Yamaji, T., and Tsugane, S. Seaweed consumption and the risk of thyroid cancer in women: the Japan Public Health Center-based Prospective Study. Eur.J.Cancer Prev. 2012;21:254-260. View abstract.
  45. Burger, J., Gochfeld, M., Jeitner, C., Donio, M., and Pittfield, T. Lead (Pb) in biota and perceptions of Pb exposure at a recently designated Superfund beach site in New Jersey. J.Toxicol.Environ.Health A 2012;75:272-287. View abstract.
  46. Capitanio, B., Sinagra, J. L., Weller, R. B., Brown, C., and Berardesca, E. Randomized controlled study of a cosmetic treatment for mild acne. Clin.Exp.Dermatol. 2012;37:346-349. View abstract.
  47. Al-Bader, T., Byrne, A., Gillbro, J., Mitarotonda, A., Metois, A., Vial, F., Rawlings, A. V., and Laloeuf, A. Effect of cosmetic ingredients as anticellulite agents: synergistic action of actives with in vitro and in vivo efficacy. J.Cosmet.Dermatol. 2012;11:17-26. View abstract.
  48. Mateu, C. G., Recalde, M. P., Artuso, M. C., Hermida, G., Linero, F. N., Scolaro, L. A., Damonte, E. B., Pujol, C. A., and Carlucci, M. J. Emergence of herpes simplex virus-1 syncytial variants with altered virulence for mice after selection with a natural carrageenan. Sex Transm.Dis. 2011;38:555-561. View abstract.
  49. Uenishi, K., Fujita, T., Ishida, H., Fujii, Y., Ohue, M., Kaji, H., Hirai, M., Kakumoto, M., and Abrams, S. A. Fractional absorption of active absorbable algal calcium (AAACa) and calcium carbonate measured by a dual stable-isotope method. Nutrients. 2010;2:752-761. View abstract.
  50. Marais, D., Gawarecki, D., Allan, B., Ahmed, K., Altini, L., Cassim, N., Gopolang, F., Hoffman, M., Ramjee, G., and Williamson, A. L. The effectiveness of Carraguard, a vaginal microbicide, in protecting women against high-risk human papillomavirus infection. Antivir.Ther. 2011;16:1219-1226. View abstract.
  51. Manzo-Silberman, S., Louedec, L., Meilhac, O., Letourneur, D., Michel, J. B., and Elmadbouh, I. Therapeutic potential of fucoidan in myocardial ischemia. J.Cardiovasc.Pharmacol. 2011;58:626-632. View abstract.
  52. Cho, H. B., Lee, H. H., Lee, O. H., Choi, H. S., Choi, J. S., and Lee, B. Y. Clinical and microbial evaluation of the effects on gingivitis of a mouth rinse containing an Enteromorpha linza extract. J.Med.Food 2011;14:1670-1676. View abstract.
  53. Kang, Y. M., Lee, B. J., Kim, J. I., Nam, B. H., Cha, J. Y., Kim, Y. M., Ahn, C. B., Choi, J. S., Choi, I. S., and Je, J. Y. Antioxidant effects of fermented sea tangle (Laminaria japonica) by Lactobacillus brevis BJ20 in individuals with high level of gamma-GT: A randomized, double-blind, and placebo-controlled clinical study. Food Chem.Toxicol. 2012;50(3-4):1166-1169. View abstract.
  54. Arbaizar, B. and Llorca, J. [Fucus vesiculosus induced hyperthyroidism in a patient undergoing concomitant treatment with lithium]. Actas Esp.Psiquiatr. 2011;39:401-403. View abstract.
  55. Hall, A. C., Fairclough, A. C., Mahadevan, K., and Paxman, J. R. Ascophyllum nodosum enriched bread reduces subsequent energy intake with no effect on post-prandial glucose and cholesterol in healthy, overweight males. A pilot study. Appetite 2012;58:379-386. View abstract.
  56. Paradis, M. E., Couture, P., and Lamarche, B. A randomised crossover placebo-controlled trial investigating the effect of brown seaweed (Ascophyllum nodosum and Fucus vesiculosus) on postchallenge plasma glucose and insulin levels in men and women. Appl.Physiol Nutr.Metab 2011;36:913-919. View abstract.
  57. Kim, S. K. and Li, Y. X. Medicinal benefits of sulfated polysaccharides from sea vegetables. Adv.Food Nutr.Res. 2011;64:391-402. View abstract.
  58. Misurcova, L., Machu, L., and Orsavova, J. Seaweed minerals as nutraceuticals. Adv.Food Nutr.Res. 2011;64:371-390. View abstract.
  59. Skrovankova, S. Seaweed vitamins as nutraceuticals. Adv.Food Nutr.Res. 2011;64:357-369. View abstract.
  60. Misurcova, L., Ambrozova, J., and Samek, D. Seaweed lipids as nutraceuticals. Adv.Food Nutr.Res. 2011;64:339-355. View abstract.
  61. Jimenez-Escrig, A., Gomez-Ordonez, E., and Ruperez, P. Seaweed as a source of novel nutraceuticals: sulfated polysaccharides and peptides. Adv.Food Nutr.Res. 2011;64:325-337. View abstract.
  62. Cerna, M. Seaweed proteins and amino acids as nutraceuticals. Adv.Food Nutr.Res. 2011;64:297-312. View abstract.
  63. Pallela, R. and Kim, S. K. Impact of marine micro- and macroalgal consumption on photoprotection. Adv.Food Nutr.Res. 2011;64:287-295. View abstract.
  64. Senevirathne, M. and Kim, S. K. Marine macro- and microalgae as potential agents for the prevention of asthma: hyperresponsiveness and inflammatory subjects. Adv.Food Nutr.Res. 2011;64:277-286. View abstract.
  65. Kim, S. K. and Karadeniz, F. Anti-HIV activity of extracts and compounds from marine algae. Adv.Food Nutr.Res. 2011;64:255-265. View abstract.
  66. Shirosaki, M. and Koyama, T. Laminaria japonica as a food for the prevention of obesity and diabetes. Adv.Food Nutr.Res. 2011;64:199-212. View abstract.
  67. Kim, S. K., Pangestuti, R., and Rahmadi, P. Sea lettuces: culinary uses and nutritional value. Adv.Food Nutr.Res. 2011;64:57-70. View abstract.
  68. Rajapakse, N. and Kim, S. K. Nutritional and digestive health benefits of seaweed. Adv.Food Nutr.Res. 2011;64:17-28. View abstract.
  69. Reilly, G. D., Reilly, C. A., Smith, E. G., and Baker-Austin, C. Vibrio alginolyticus-associated wound infection acquired in British waters, Guernsey, July 2011. Euro.Surveill 2011;16 View abstract.
  70. Thomas, N. V. and Kim, S. K. Potential pharmacological applications of polyphenolic derivatives from marine brown algae. Environ.Toxicol.Pharmacol. 2011;32:325-335. View abstract.
  71. Jeukendrup, A. E. and Randell, R. Fat burners: nutrition supplements that increase fat metabolism. Obes.Rev. 2011;12:841-851. View abstract.
  72. Hashimoto, T., Ozaki, Y., Mizuno, M., Yoshida, M., Nishitani, Y., Azuma, T., Komoto, A., Maoka, T., Tanino, Y., and Kanazawa, K. Pharmacokinetics of fucoxanthinol in human plasma after the oral administration of kombu extract. Br.J.Nutr. 2012;107:1566-1569. View abstract.
  73. Shin, H. C., Kim, S. H., Park, Y., Lee, B. H., and Hwang, H. J. Effects of 12-week oral supplementation of Ecklonia cava polyphenols on anthropometric and blood lipid parameters in overweight Korean individuals: a double-blind randomized clinical trial. Phytother.Res. 2012;26:363-368. View abstract.
  74. Pangestuti, R. and Kim, S. K. Neuroprotective effects of marine algae. Mar.Drugs 2011;9:803-818. View abstract.
  75. Miyashita, K., Nishikawa, S., Beppu, F., Tsukui, T., Abe, M., and Hosokawa, M. The allenic carotenoid fucoxanthin, a novel marine nutraceutical from brown seaweeds. J.Sci.Food Agric. 2011;91:1166-1174. View abstract.
  76. Araya, N., Takahashi, K., Sato, T., Nakamura, T., Sawa, C., Hasegawa, D., Ando, H., Aratani, S., Yagishita, N., Fujii, R., Oka, H., Nishioka, K., Nakajima, T., Mori, N., and Yamano, Y. Fucoidan therapy decreases the proviral load in patients with human T-lymphotropic virus type-1-associated neurological disease. Antivir.Ther. 2011;16:89-98. View abstract.
  77. Emder, P. J. and Jack, M. M. Iodine-induced neonatal hypothyroidism secondary to maternal seaweed consumption: a common practice in some Asian cultures to promote breast milk supply. J.Paediatr.Child Health 2011;47:750-752. View abstract.
  78. Jones, R. Unusual fucoidin-binding properties of chymotrypsinogen and trypsinogen. Biochim.Biophys.Acta 2-9-1990;1037:227-232. View abstract.
  79. Wijesekara, I., Yoon, N. Y., and Kim, S. K. Phlorotannins from Ecklonia cava (Phaeophyceae): biological activities and potential health benefits. Biofactors 2010;36:408-414. View abstract.
  80. Miyashita, S. and Kaise, T. [Biological effects and metabolism of arsenic compounds present in seafood products]. Shokuhin Eiseigaku Zasshi 2010;51:71-91. View abstract.
  81. Almeida-Lima, J., Costa, L. S., Silva, N. B., Melo-Silveira, R. F., Silva, F. V., Felipe, M. B., Medeiros, S. R., Leite, E. L., and Rocha, H. A. Evaluating the possible genotoxic, mutagenic and tumor cell proliferation-inhibition effects of a non-anticoagulant, but antithrombotic algal heterofucan. J.Appl.Toxicol. 2010;30:708-715. View abstract.
  82. Ciancia, M., Quintana, I., and Cerezo, A. S. Overview of anticoagulant activity of sulfated polysaccharides from seaweeds in relation to their structures, focusing on those of green seaweeds. Curr.Med.Chem. 2010;17:2503-2529. View abstract.
  83. Matanjun, P., Mohamed, S., Muhammad, K., and Mustapha, N. M. Comparison of cardiovascular protective effects of tropical seaweeds, Kappaphycus alvarezii, Caulerpa lentillifera, and Sargassum polycystum, on high-cholesterol/high-fat diet in rats. J.Med.Food 2010;13:792-800. View abstract.
  84. Oh, J. K., Shin, Y. O., Yoon, J. H., Kim, S. H., Shin, H. C., and Hwang, H. J. Effect of supplementation with Ecklonia cava polyphenol on endurance performance of college students. Int.J.Sport Nutr.Exerc.Metab 2010;20:72-79. View abstract.
  85. Odunsi, S. T., Vazquez-Roque, M. I., Camilleri, M., Papathanasopoulos, A., Clark, M. M., Wodrich, L., Lempke, M., McKinzie, S., Ryks, M., Burton, D., and Zinsmeister, A. R. Effect of alginate on satiation, appetite, gastric function, and selected gut satiety hormones in overweight and obesity. Obesity.(Silver.Spring) 2010;18:1579-1584. View abstract.
  86. Costa, L. S., Fidelis, G. P., Cordeiro, S. L., Oliveira, R. M., Sabry, D. A., Camara, R. B., Nobre, L. T., Costa, M. S., Almeida-Lima, J., Farias, E. H., Leite, E. L., and Rocha, H. A. Biological activities of sulfated polysaccharides from tropical seaweeds. Biomed.Pharmacother. 2010;64:21-28. View abstract.
  87. Teas, J., Baldeon, M. E., Chiriboga, D. E., Davis, J. R., Sarries, A. J., and Braverman, L. E. Could dietary seaweed reverse the metabolic syndrome? Asia Pac.J.Clin.Nutr. 2009;18:145-154. View abstract.
  88. Irhimeh, M. R., Fitton, J. H., and Lowenthal, R. M. Pilot clinical study to evaluate the anticoagulant activity of fucoidan. Blood Coagul.Fibrinolysis 2009;20:607-610. View abstract.
  89. Steinmaus, C., Yuan, Y., Liaw, J., and Smith, A. H. Low-level population exposure to inorganic arsenic in the United States and diabetes mellitus: a reanalysis. Epidemiology 2009;20:807-815. View abstract.
  90. Fluhr, J. W., Breternitz, M., Kowatzki, D., Bauer, A., Bossert, J., Elsner, P., and Hipler, U. C. Silver-loaded seaweed-based cellulosic fiber improves epidermal skin physiology in atopic dermatitis: safety assessment, mode of action and controlled, randomized single-blinded exploratory in vivo study. Exp.Dermatol. 2010;19:e9-15. View abstract.
  91. Koetzner, L., Grover, G., Boulet, J., and Jacoby, H. I. Plant-derived polysaccharide supplements inhibit dextran sulfate sodium-induced colitis in the rat. Dig.Dis Sci 2010;55:1278-1285. View abstract.
  92. Bocanegra, A., Bastida, S., Benedi, J., Rodenas, S., and Sanchez-Muniz, F. J. Characteristics and nutritional and cardiovascular-health properties of seaweeds. J.Med.Food 2009;12:236-258. View abstract.
  93. Vasilevskaia, L. S., Pogozheva, A. V., Derbeneva, S. A., Zorin, S. N., Buchanova, A. V., Abramova, L. S., Petrukhanova, A. V., Gmoshinskii, I. V., and Mazo, V. K. [Clinical efficiency of using laminaria jam enriched with selenium]. Vopr.Pitan. 2009;78:79-83. View abstract.
  94. Novak, M. and Vetvicka, V. Glucans as biological response modifiers. Endocr.Metab Immune.Disord.Drug Targets. 2009;9:67-75. View abstract.
  95. Holm, M., Johannesson, S., Toren, K., and Dahlman-Hoglund, A. Acute effects after occupational endotoxin exposure at a spa. Scand.J.Work Environ.Health 2009;35:153-155. View abstract.
  96. Frestedt, J. L., Kuskowski, M. A., and Zenk, J. L. A natural seaweed derived mineral supplement (Aquamin F) for knee osteoarthritis: a randomised, placebo controlled pilot study. Nutr.J. 2009;8:7. View abstract.
  97. Tseng, C. H. A review on environmental factors regulating arsenic methylation in humans. Toxicol.Appl.Pharmacol. 3-15-2009;235:338-350. View abstract.
  98. Miao, C., Du, J., Dang, H. T., Jeong, I. H., You, S., Park, J. S., Jung, J. H., and Kim, D. K. Apoptotic activity of fatty acid derivatives may correlate with their inhibition of DNA replication. Int.J.Oncol. 2008;33:1291-1298. View abstract.
  99. Wasiak, J., Cleland, H., and Campbell, F. Dressings for superficial and partial thickness burns. Cochrane.Database.Syst.Rev. 2008;:CD002106. View abstract.
  100. Yang, C., Chung, D., Shin, I. S., Lee, H., Kim, J., Lee, Y., and You, S. Effects of molecular weight and hydrolysis conditions on anticancer activity of fucoidans from sporophyll of Undaria pinnatifida. Int.J.Biol.Macromol. 2008;43:433-437. View abstract.
  101. Fowler, E. and Papen, J. C. Evaluation of an alginate dressing for pressure ulcers. Decubitus. 1991;4:47-8, 50, 52. View abstract.
  102. Kile, M. L. and Christiani, D. C. Environmental arsenic exposure and diabetes. JAMA 8-20-2008;300:845-846. View abstract.
  103. Navas-Acien, A., Silbergeld, E. K., Pastor-Barriuso, R., and Guallar, E. Arsenic exposure and prevalence of type 2 diabetes in US adults. JAMA 8-20-2008;300:814-822. View abstract.
  104. Asakawa, M. [Aquatic biotoxins in relation to food poisonings]. Chudoku.Kenkyu 2008;21:285-292. View abstract.
  105. Miyai, K., Tokushige, T., and Kondo, M. Suppression of thyroid function during ingestion of seaweed "Kombu" (Laminaria japonoca) in normal Japanese adults. Endocr.J. 2008;55:1103-1108. View abstract.
  106. Paxman, J. R., Richardson, J. C., Dettmar, P. W., and Corfe, B. M. Daily ingestion of alginate reduces energy intake in free-living subjects. Appetite 2008;51:713-719. View abstract.
  107. Kilmarx, P. H., Blanchard, K., Chaikummao, S., Friedland, B. A., Srivirojana, N., Connolly, C., Witwatwongwana, P., Supawitkul, S., Mock, P. A., Chaowanachan, T., and Tappero, J. A randomized, placebo-controlled trial to assess the safety and acceptability of use of carraguard vaginal gel by heterosexual couples in Thailand. Sex Transm.Dis. 2008;35:226-232. View abstract.
  108. Dillehay, T. D., Ramirez, C., Pino, M., Collins, M. B., Rossen, J., and Pino-Navarro, J. D. Monte Verde: seaweed, food, medicine, and the peopling of South America. Science 5-9-2008;320:784-786. View abstract.
  109. Novak, M. and Vetvicka, V. Beta-glucans, history, and the present: immunomodulatory aspects and mechanisms of action. J.Immunotoxicol. 2008;5:47-57. View abstract.
  110. Landa, N., Miller, L., Feinberg, M. S., Holbova, R., Shachar, M., Freeman, I., Cohen, S., and Leor, J. Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation 3-18-2008;117:1388-1396. View abstract.
  111. Frestedt, J. L., Walsh, M., Kuskowski, M. A., and Zenk, J. L. A natural mineral supplement provides relief from knee osteoarthritis symptoms: a randomized controlled pilot trial. Nutr J 2008;7:9. View abstract.
  112. MacArtain, P., Gill, C. I., Brooks, M., Campbell, R., and Rowland, I. R. Nutritional value of edible seaweeds. Nutr.Rev. 2007;65(12 Pt 1):535-543. View abstract.
  113. van de Wijgert, J. H., Braunstein, S. L., Morar, N. S., Jones, H. E., Madurai, L., Strickfaden, T. T., Moodley, M., Aboobaker, J., Ndlovu, G., Ferguson, T. M., Friedland, B. A., Hart, C. E., and Ramjee, G. Carraguard Vaginal Gel Safety in HIV-Positive Women and Men in South Africa. J.Acquir.Immune.Defic.Syndr. 12-15-2007;46:538-546. View abstract.
  114. Hayashi, T. [Studies on evaluation of natural products for antiviral effects and their applications]. Yakugaku Zasshi 2008;128:61-79. View abstract.
  115. Colliec S, Fischer AM, Tapon-Bretaudiere J, and et al. Anticoagulant properties of a fucoidan fraction. Thromb Res 10-15-1991;64:143-154. View abstract.
  116. Heenan, A. Alginates: an effective primary dressing for exuding wounds. Nurs.Stand. 10-24-2007;22:53-4, 56, 58. View abstract.
  117. Watanabe, F. Vitamin B12 sources and bioavailability. Exp.Biol.Med.(Maywood.) 2007;232:1266-1274. View abstract.
  118. Rowe, B. R., Bain, S. C., Pizzey, M., and Barnett, A. H. Rapid healing of ulcerated necrobiosis lipoidica with optimum glycaemic control and seaweed-based dressings. Br.J.Dermatol. 1991;125:603-604. View abstract.
  119. Freguin-Bouilland, C., Alkhatib, B., David, N., Lallemand, F., Henry, J. P., Godin, M., Thuillez, C., and Plissonnier, D. Low molecular weight fucoidan prevents neointimal hyperplasia after aortic allografting. Transplantation 5-15-2007;83:1234-1241. View abstract.
  120. Teas, J., Braverman, L. E., Kurzer, M. S., Pino, S., Hurley, T. G., and Hebert, J. R. Seaweed and soy: companion foods in Asian cuisine and their effects on thyroid function in American women. J Med Food 2007;10:90-100. View abstract.
  121. Bhattacharyya, S., Borthakur, A., Dudeja, P. K., and Tobacman, J. K. Carrageenan reduces bone morphogenetic protein-4 (BMP4) and activates the Wnt/beta-catenin pathway in normal human colonocytes. Dig.Dis.Sci. 2007;52:2766-2774. View abstract.
  122. Cumashi, A., Ushakova, N. A., Preobrazhenskaya, M. E., D'Incecco, A., Piccoli, A., Totani, L., Tinari, N., Morozevich, G. E., Berman, A. E., Bilan, M. I., Usov, A. I., Ustyuzhanina, N. E., Grachev, A. A., Sanderson, C. J., Kelly, M., Rabinovich, G. A., Iacobelli, S., and Nifantiev, N. E. A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds. Glycobiology 2007;17:541-552. View abstract.
  123. Nelson, E. A. and Bradley, M. D. Dressings and topical agents for arterial leg ulcers. Cochrane.Database.Syst.Rev. 2007;:CD001836. View abstract.
  124. Queiroz, K. C., Assis, C. F., Medeiros, V. P., Rocha, H. A., Aoyama, H., Ferreira, C. V., and Leite, E. L. Cytotoxicity effect of algal polysaccharides on HL60 cells. Biochemistry (Mosc.) 2006;71:1312-1315. View abstract.
  125. Lamberg, B. A. Endemic goitre--iodine deficiency disorders. Ann.Med. 1991;23:367-372. View abstract.
  126. Yamaguchi, M. Regulatory mechanism of food factors in bone metabolism and prevention of osteoporosis. Yakugaku Zasshi 2006;126:1117-1137. View abstract.
  127. Athukorala, Y., Lee, K. W., Kim, S. K., and Jeon, Y. J. Anticoagulant activity of marine green and brown algae collected from Jeju Island in Korea. Bioresour.Technol. 2007;98:1711-1716. View abstract.
  128. Palfreyman, S. J., Nelson, E. A., Lochiel, R., and Michaels, J. A. Dressings for healing venous leg ulcers. Cochrane.Database.Syst.Rev. 2006;:CD001103. View abstract.
  129. Picco, G., Dios-Romero, A., Albanell, N., and Badia, J. [Regular intake of seaweed and hyperthyroidism]. Med Clin (Barc.) 7-1-2006;127:199. View abstract.
  130. Mussig, K., Thamer, C., Bares, R., Lipp, H. P., Haring, H. U., and Gallwitz, B. Iodine-induced thyrotoxicosis after ingestion of kelp-containing tea. J Gen.Intern Med 2006;21:C11-C14. View abstract.
  131. Maeda, H., Hosokawa, M., Sashima, T., Takahashi, N., Kawada, T., and Miyashita, K. Fucoxanthin and its metabolite, fucoxanthinol, suppress adipocyte differentiation in 3T3-L1 cells. Int.J.Mol.Med. 2006;18:147-152. View abstract.
  132. Irhimeh, M. R., Fitton, J. H., Lowenthal, R. M., and Kongtawelert, P. A quantitative method to detect fucoidan in human plasma using a novel antibody. Methods Find.Exp.Clin.Pharmacol. 2005;27:705-710. View abstract.
  133. Tran, H. A. Inadvertent iodine excess causing thyrotoxic hypokalemic periodic paralysis. Arch.Intern.Med. 11-28-2005;165:2536. View abstract.
  134. Croft, M. T., Lawrence, A. D., Raux-Deery, E., Warren, M. J., and Smith, A. G. Algae acquire vitamin B12 through a symbiotic relationship with bacteria. Nature 11-3-2005;438:90-93. View abstract.
  135. Rudichenko, E. V., Gvozdenko, T. A., and Antoniuk, M. V. [Impact of dietotherapy with enterosorbent of marine origin on the indices of mineral and lipid metabolism for patients suffering from kidney diseases]. Vopr.Pitan. 2005;74:33-35. View abstract.
  136. Strand, J. and Jacobsen, J. A. Accumulation and trophic transfer of organotins in a marine food web from the Danish coastal waters. Sci.Total Environ. 11-1-2005;350(1-3):72-85. View abstract.
  137. Moriyama, K., Kanamoto, N., Hataya, Y., Nanbu, T., Hosoda, K., Arai, H., and Nakao, K. A case of type 2 diabetes mellitus developing hypothyroidism discovered as a result of a discrepancy between glycated hemoglobin and glycated albumin values. Diabetes Res.Clin.Pract. 2006;71:227-232. View abstract.
  138. Tokumine, J., Sugahara, K., Fuchigami, T., Teruya, K., Nitta, K., and Satou, K. Unanticipated full stomach at anesthesia induction in a type I diabetic patient with asymptomatic gastroparesis. J.Anesth. 2005;19:247-248. View abstract.
  139. Heo, S. J., Park, E. J., Lee, K. W., and Jeon, Y. J. Antioxidant activities of enzymatic extracts from brown seaweeds. Bioresour.Technol. 2005;96:1613-1623. View abstract.
  140. Silva, T. M., Alves, L. G., de Queiroz, K. C., Santos, M. G., Marques, C. T., Chavante, S. F., Rocha, H. A., and Leite, E. L. Partial characterization and anticoagulant activity of a heterofucan from the brown seaweed Padina gymnospora. Braz.J.Med.Biol.Res. 2005;38:523-533. View abstract.
  141. Maeda, H., Hosokawa, M., Sashima, T., Funayama, K., and Miyashita, K. Fucoxanthin from edible seaweed, Undaria pinnatifida, shows antiobesity effect through UCP1 expression in white adipose tissues. Biochem.Biophys.Res.Commun. 7-1-2005;332:392-397. View abstract.
  142. Sugimoto, K. and Ninomiya, Y. Introductory remarks on umami research: candidate receptors and signal transduction mechanisms on umami. Chem.Senses 2005;30 Suppl 1:i21-i22. View abstract.
  143. Na, H. J., Moon, P. D., Ko, S. G., Lee, H. J., Jung, H. A., Hong, S. H., Seo, Y., Oh, J. M., Lee, B. H., Choi, B. W., and Kim, H. M. Sargassum hemiphyllum inhibits atopic allergic reaction via the regulation of inflammatory mediators. J.Pharmacol.Sci. 2005;97:219-226. View abstract.
  144. Hoornstra, D., Andersson, M. A., Johansson, T., Pirhonen, T., Hatakka, M., and Salkinoja-Salonen, M. S. Mitochondrial toxicity detected in a health product with a boar spermatozoan bioassay. Altern.Lab Anim 2004;32:407-416. View abstract.
  145. Damonte, E. B., Matulewicz, M. C., and Cerezo, A. S. Sulfated seaweed polysaccharides as antiviral agents. Curr.Med Chem. 2004;11:2399-2419. View abstract.
  146. Andrewes, P., Demarini, D. M., Funasaka, K., Wallace, K., Lai, V. W., Sun, H., Cullen, W. R., and Kitchin, K. T. Do arsenosugars pose a risk to human health? The comparative toxicities of a trivalent and pentavalent arsenosugar. Environ.Sci.Technol. 8-1-2004;38:4140-4148. View abstract.
  147. Soeda S, Sakaguchi S, Shimeno H, and et al. Fibrinolytic and anticoagulant activities of highly sulfated fucoidan. Biochem Pharmacol 4-15-1992;43:1853-1858. View abstract.
  148. Vermeulen, H., Ubbink, D., Goossens, A., de, Vos R., and Legemate, D. Dressings and topical agents for surgical wounds healing by secondary intention. Cochrane.Database.Syst.Rev. 2004;:CD003554. View abstract.
  149. Chandrakumar, M. Could contact with seaweed cause skin blisters? Public Health 1992;106:482-485. View abstract.
  150. Clark, C. D., Bassett, B., and Burge, M. R. Effects of kelp supplementation on thyroid function in euthyroid subjects. Endocr.Pract. 2003;9:363-369. View abstract.
  151. Shibata, Y., Morita, M., and Fuwa, K. Selenium and arsenic in biology: their chemical forms and biological functions. Adv.Biophys. 1992;28:31-80. View abstract.
  152. SPRINGER, G. F., WURZEL, H. A., and Mcneal, G. M. et al. Isolation of anticoagulant fractions from crude fucoidin. Proc.Soc.Exp.Biol.Med 1957;94:404-409. View abstract.
  153. Teodoru, V. and Nicolau, G. Y. Iodine-enriched milk in goiter endemics. Rom.J.Endocrinol. 1992;30(3-4):165-167. View abstract.
  154. Harrell BL and Rudolph AH. Letter: kelp diet: a cause of acneiform eruption. Arch.Dermatol. 1976;112:560. View abstract.
  155. Bell, J., Duhon, S., and Doctor, V. M. The effect of fucoidan, heparin and cyanogen bromide-fibrinogen on the activation of human glutamic-plasminogen by tissue plasminogen activator. Blood Coagul.Fibrinolysis 2003;14:229-234. View abstract.
  156. Cooper, R., Dragar, C., Elliot, K., Fitton, J. H., Godwin, J., and Thompson, K. GFS, a preparation of Tasmanian Undaria pinnatifida is associated with healing and inhibition of reactivation of Herpes. BMC.Complement Altern.Med. 11-20-2002;2:11. View abstract.
  157. Hsueh, Y. M., Hsu, M. K., Chiou, H. Y., Yang, M. H., Huang, C. C., and Chen, C. J. Urinary arsenic speciation in subjects with or without restriction from seafood dietary intake. Toxicol.Lett. 7-7-2002;133:83-91. View abstract.
  158. Salas, Coronas J., Cruz, Caparros G., Laynez, Bretones F., and Diez, Garcia F. [Hyperthyroidism secondary to kelp tablets ingestias]. Med.Clin.(Barc.) 6-1-2002;118:797-798. View abstract.
  159. Murakami, C., Takemura, M., Sugiyama, Y., Kamisuki, S., Asahara, H., Kawasaki, M., Ishidoh, T., Linn, S., Yoshida, S., Sugawara, F., Yoshida, H., Sakaguchi, K., and Mizushina, Y. Vitamin A-related compounds, all-trans retinal and retinoic acids, selectively inhibit activities of mammalian replicative DNA polymerases. Biochim.Biophys.Acta 2-20-2002;1574:85-92. View abstract.
  160. Knowles, S. R., Djordjevic, K., Binkley, K., and Weber, E. A. Allergic anaphylaxis to Laminaria. Allergy 2002;57:370. View abstract.
  161. Walkiw O and Douglas DE. Health food supplements prepared from kelp--a source of elevated urinary arsenic. Clin Toxicol 1975;8:325-331. View abstract.
  162. Matsubayashi, S., Mukuta, T., Watanabe, H., Fuchigami, H., Taniguchi, J., Chinen, M., Ninomiya, H., and Sasaki, H. Iodine-induced hypothyroidism as a result of excessive intake of confectionery made with tangle weed, Kombu, used as a low calorie food during a bulimic period in a patient with anorexia nervosa. Eat.Weight.Disord. 1998;3:50-52. View abstract.
  163. Matsuse, H., Shimoda, T., Kawano, T., Fukushima, C., Mitsuta, K., Obase, Y., Tomari, S., Saeki, S., and Kohno, S. Airway foreign body with clinical features mimicking bronchial asthma. Respiration 2001;68:103-105. View abstract.
  164. Funahashi, H. [Chemopreventive effect of tamoxifen on familial breast cancer]. Nihon Rinsho 2000;58:1267-1271. View abstract.
  165. Hou, X., Dahlgaard, H., Nielsen, S. P., and Ding, W. Iodine-129 in human thyroids and seaweed in China. Sci.Total Environ. 2-10-2000;246(2-3):285-291. View abstract.
  166. Yamada, K., Yamada, Y., Fukuda, M., and Yamada, S. Bioavailability of dried asakusanori (porphyra tenera) as a source of Cobalamin (Vitamin B12). Int.J.Vitam.Nutr.Res. 1999;69:412-418. View abstract.
  167. Nishino, T., Fukuda, A., Nagumo, T., Fujihara, M., and Kaji, E. Inhibition of the generation of thrombin and factor Xa by a fucoidan from the brown seaweed Ecklonia kurome. Thromb.Res. 10-1-1999;96:37-49. View abstract.
  168. Jimenez-Escrig, A. and Goni, Cambrodon, I. [Nutritional evaluation and physiological effects of edible seaweeds]. Arch.Latinoam.Nutr. 1999;49:114-120. View abstract.
  169. Nagai, K., Hosaka, H., Kubo, S., Nakabayashi, T., Amagasaki, Y., and Nakamura, N. Vitamin A toxicity secondary to excessive intake of yellow-green vegetables, liver and laver. J.Hepatol. 1999;31:142-148. View abstract.
  170. Barnaby, F. and Boeker, E. Is technetium-99 (Tc-99) radiologically significant? Med.Confl.Surviv. 1999;15:57-70. View abstract.
  171. Abidov, M., Ramazanov, Z., Seifulla, R., and Grachev, S. The effects of Xanthigen in the weight management of obese premenopausal women with non-alcoholic fatty liver disease and normal liver fat. Diabetes Obes.Metab 2010;12:72-81. View abstract.
  172. Aquaron, R., Delange, F., Marchal, P., Lognone, V., and Ninane, L. Bioavailability of seaweed iodine in human beings. Cell Mol.Biol.(Noisy.-le-grand) 2002;48:563-569. View abstract.
  173. Lis-Balchin, M. Parallel placebo-controlled clinical study of a mixture of herbs sold as a remedy for cellulite. Phytother.Res. 1999;13:627-629. View abstract.
  174. Catania, M. A., Oteri, A., Caiello, P., Russo, A., Salvo, F., Giustini, E. S., Caputi, A. P., and Polimeni, G. Hemorrhagic cystitis induced by an herbal mixture. South.Med.J. 2010;103:90-92. View abstract.
  175. Bezpalov, V. G., Barash, N. I., Ivanova, O. A., Semenov, I. I., Aleksandrov, V. A., and Semiglazov, V. F. [Investigation of the drug "Mamoclam" for the treatment of patients with fibroadenomatosis of the breast]. Vopr.Onkol. 2005;51:236-241. View abstract.
  176. Whitehead, S. J., Kilmarx, P. H., Blanchard, K., Manopaiboon, C., Chaikummao, S., Friedland, B., Achalapong, J., Wankrairoj, M., Mock, P., Thanprasertsuk, S., and Tappero, J. W. Acceptability of Carraguard vaginal gel use among Thai couples. AIDS 11-14-2006;20:2141-2148. View abstract.
  177. Coggins, C., Blanchard, K., Alvarez, F., Brache, V., Weisberg, E., Kilmarx, P. H., Lacarra, M., Massai, R., Mishell, D., Jr., Salvatierra, A., Witwatwongwana, P., Elias, C., and Ellertson, C. Preliminary safety and acceptability of a carrageenan gel for possible use as a vaginal microbicide. Sex Transm.Infect. 2000;76:480-483. View abstract.
  178. Dumelod, B. D., Ramirez, R. P., Tiangson, C. L., Barrios, E. B., and Panlasigui, L. N. Carbohydrate availability of arroz caldo with lambda-carrageenan. Int.J.Food Sci.Nutr. 1999;50:283-289. View abstract.
  179. Colin, Slaughter J. The naturally occurring furanones: formation and function from pheromone to food. Biol Rev Camb.Philos.Soc 1999;74:259-276. View abstract.
  180. Burack, J. H., Cohen, M. R., Hahn, J. A., and Abrams, D. I. Pilot randomized controlled trial of Chinese herbal treatment for HIV- associated symptoms. J Acquir.Immune.Defic.Syndr.Hum.Retrovirol. 8-1-1996;12:386-393. View abstract.
  181. Kang K, Hwang HJ, Hong DH, et al. Antioxidant and antiinflammatory activities of ventol, a phlorotannin-rich natural agent derived from Ecklonia cava, and its effect on proteoglycan degradation in cartilage explant culture. Res Commun Mol Pathol Pharmacol 2004;115-116:77-95. View abstract.
  182. Amster E, Tiwary A, Schenker MB. Case report: potential arsenic toxicosis secondary to herbal kelp supplement. Environ Health Perspect 2007;115:606-8. View abstract.
  183. US Department of Health and Human Services, Public Health Service. Agency for Toxic Substances and Disease Registry. Toxicological profile for strontium. April 2004. Available at: www.atsdr.cdc.gov/toxprofiles/tp159.pdf. (Accessed 8 August 2006).
  184. Agarwal SC, Crook JR, Pepper CB. Herbal remedies -- how safe are they? A case report of polymorphic ventricular tachycardia/ventricular fibrillation induced by herbal medication used for obesity. Int J Cardiol 2006;106:260-1. View abstract.
  185. Okamura K, Inoue K, Omae T. A case of Hashimoto's thyroiditis with thyroid immunological abnormality manifested after habitual ingestion of seaweed. Acta Endocrinol (Copenh) 1978;88:703-12. View abstract.
  186. Bjorvell H, Rössner S. Long-term effects of commonly available weight reducing programmes in Sweden. Int J Obes 1987;11:67-71. . View abstract.
  187. Ohye H, Fukata S, Kanoh M, et al. Thyrotoxicosis caused by weight-reducing herbal medicines. Arch Intern Med 2005;165:831-4. View abstract.
  188. Conz PA, La Greca G, Benedetti P, et al. Fucus vesiculosus: a nephrotoxic alga? Nephrol Dial Transplant 1998;13:526-7. View abstract.
  189. Fujimura T, Tsukahara K, Moriwaki S, et al. Treatment of human skin with an extract of Fucus vesiculosus changes its thickness and mechanical properties. J Cosmet Sci 2002;53:1-9. View abstract.
  190. Koyanagi S, Tanigawa N, Nakagawa H, et al. Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities. Biochem Pharmacol 2003;65:173-9. View abstract.
  191. Durig J, Bruhn T, Zurborn KH, et al. Anticoagulant fucoidan fractions from Fucus vesiculosus induce platelet activation in vitro. Thromb Res 1997;85:479-91. View abstract.
  192. O'Leary R, Rerek M, Wood EJ. Fucoidan modulates the effect of transforming growth factor (TGF)-beta1 on fibroblast proliferation and wound repopulation in in vitro models of dermal wound repair. Biol Pharm Bull 2004;27:266-70. View abstract.
  193. Patankar MS, Oehninger S, Barnett T, et al. A revised structure for fucoidan may explain some of its biological activities. J Biol Chem 1993;268:21770-6. View abstract.
  194. Baba M, Snoeck R, Pauwels R, de Clercq E. Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus. Antimicrob Agents Chemother 1988;32:1742-5. View abstract.
  195. Ruperez P, Ahrazem O, Leal JA. Potential antioxidant capacity of sulfated polysaccharides from the edible marine brown seaweed Fucus vesiculosus. J Agric Food Chem 2002;50:840-5. View abstract.
  196. Beress A, Wassermann O, Tahhan S, et al. A new procedure for the isolation of anti-HIV compounds (polysaccharides and polyphenols) from the marine alga Fucus vesiculosus. J Nat Prod 1993;56:478-88. View abstract.
  197. Criado MT, Ferreiros CM. Toxicity of an algal mucopolysaccharide for Escherichia coli and Neisseria meningitidis strains. Rev Esp Fisiol 1984;40:227-30. View abstract.
  198. Skibola CF. The effect of Fucus vesiculosus, an edible brown seaweed, upon menstrual cycle length and hormonal status in three pre-menopausal women: a case report. BMC Complement Altern Med 2004;4:10. View abstract.
  199. Phaneuf D, Cote I, Dumas P, et al. Evaluation of the contamination of marine algae (Seaweed) from the St. Lawrence River and likely to be consumed by humans. Environ Res 1999;80:S175-S182. View abstract.
  200. Baker DH. Iodine toxicity and its amelioration. Exp Biol Med (Maywood) 2004;229:473-8. View abstract.
  201. Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: National Academy Press, 2002. Available at: www.nap.edu/books/0309072794/html/.
  202. Harvey J, Colin-Jones DG. Mistletoe hepatitis. Br Med J (Clin Res Ed) 1981;282:186-7. View abstract.
  203. Pye KG, Kelsey SM, House IM, et al. Severe dyserythropoeisis and autoimmune thrombocytopenia associated with ingestion of kelp supplement. Lancet 1992;339:1540. View abstract.
Mostrar más referencias
Mostrar menos referencias
Documento revisado - 13/12/2011




Página actualizada 27 octubre 2014